Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Yip, Ming Shum ^a   Leung, Nancy Hiu Lan ^a   Cheung, Chung Yan ^b   Li, Ping Hung ^a   Lee, Horace Hok Yeung ^a   Daëron, Marc ^c,d   Peiris, Joseph Sriyal Malik ^a   Bruzzone, Roberto ^a,c   Jaume, Martial ^a  

^a HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c INSTITUT PASTEUR   (France)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

Antibodies; Antibody dependent enhancement; Fc receptor; Macrophage; Pseudotypes; SARS CoV; Spike

Indexed keywords

ANTIBODY; ANTISERUM; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ANTIBODY DEPENDENT ENHANCEMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CORONAVIRUS INFECTION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFECTION SENSITIVITY; MACROPHAGE; MONOCYTE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; VIRUS REPLICATION; CELL CULTURE; ENDOCYTOSIS; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

SARS CORONAVIRUS;

ANTIBODIES, VIRAL; CELLS, CULTURED; ENDOCYTOSIS; HUMANS; MACROPHAGES; MICROSCOPY, FLUORESCENCE; REAL-TIME POLYMERASE CHAIN REACTION; SARS VIRUS;

EID: 84900834595     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-82     Document Type: Article

References (48)

1. Severe acute respiratory syndrome. Peiris JS, Guan Y, Yuen KY, Nat Med 2004 10 88 S97 10.1038/nm1143 15577937 (Pubitemid 40018232)
2. Update on avian influenza A (H5N1) virus infection in humans. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N, Soeroso S, Uyeki TM, Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza AV, N Engl J Med 2008 358 261 273 18199865
3. An influenza A H1N1 virus revival-pandemic H1N1/09 virus. Michaelis M, Doerr HW, Cinatl J Jr, Infection 2009 37 381 389 10.1007/s15010-009-9181-5 19768379
4. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA, MBio 2012 3 00473 12 23170002
5. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA, N Engl J Med 2012 367 1814 1820 10.1056/NEJMoa1211721 23075143
6. Human infection with a novel avian-origin influenza A (H7N9) virus. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, et al. N Engl J Med 2013 368 1888 1897 10.1056/NEJMoa1304459 23577628
7. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, Bi Y, Wu Y, Li X, Yan J, Liu W, Zhao G, Yang W, Wang Y, Ma J, Shu Y, Lei F, Gao GF, Lancet 2013 381 1926 1932 10.1016/S0140-6736(13)60938-1 23643111
8. Multiple organ infection and the pathogenesis of SARS. Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, Zou W, Zhan J, Wang S, Xie Z, Zhuang H, Wu B, Zhong H, Shao H, Fang W, Gao D, Pei F, Li X, He Z, Xu D, Shi X, Anderson VM, Leong AS, J Exp Med 2005 202 415 424 10.1084/jem.20050828 16043521 (Pubitemid 41126959)
9. SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. Li L, Wo J, Shao J, Zhu H, Wu N, Li M, Yao H, Hu M, Dennin RH, J Clin Virol 2003 28 239 244 10.1016/S1386-6532(03)00195-1 14522061 (Pubitemid 37159363)
10. SARS-coronavirus replication in human peripheral monocytes/macrophages. Yilla M, Harcourt BH, Hickman CJ, McGrew M, Tamin A, Goldsmith CS, Bellini WJ, Anderson LJ, Virus Res 2005 107 93 101 10.1016/j.virusres.2004.09.004 15567038 (Pubitemid 39574669)
11. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H, J Pathol 2004 203 631 637 10.1002/path.1570 15141377 (Pubitemid 38714099)
12. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. Harmer D, Gilbert M, Borman R, Clark KL, FEBS Lett 2002 532 107 110 10.1016/S0014-5793(02)03640-2 12459472 (Pubitemid 35375876)
13. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, Thomas WD Jr, Thackray LB, Young MD, Mason RJ, Ambrosino DM, Wentworth DE, Demartini JC, Holmes KV, Proc Natl Acad Sci U S A 2004 101 15748 15753 10.1073/pnas.0403812101 15496474 (Pubitemid 39473559)
14. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ, J Virol 2004 78 5642 5650 10.1128/JVI.78.11.5642-5650.2004 15140961 (Pubitemid 38661651)
15. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. Kam YW, Kien F, Roberts A, Cheung YC, Lamirande EW, Vogel L, Chu SL, Tse J, Guarner J, Zaki SR, Subbarao K, Peiris M, Nal B, Altmeyer R, Vaccine 2007 25 729 740 10.1016/j.vaccine.2006.08.011 17049691 (Pubitemid 44856104)
16. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcgammaR pathway. Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, Dutry I, Callendret B, Escriou N, Altmeyer R, Nal B, Daëron M, Bruzzone R, Peiris JS, J Virol 2011 85 10582 10597 10.1128/JVI.00671-11 21775467
17. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. Kam YW, Okumura Y, Kido H, Ng LF, Bruzzone R, Altmeyer R, PLoS One 2009 4 7870 10.1371/journal.pone.0007870 19924243
18. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. Olsen CW, Corapi WV, Ngichabe CK, Baines JD, Scott FW, J Virol 1992 66 956 965 1309922
19. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Sauter P, Hober D, Microbes Infect 2009 11 443 451 10.1016/j.micinf.2009.01.005 19399964
20. Antibody-mediated enhancement of viral disease. Sullivan NJ, Curr Top Microbiol Immunol 2001 260 145 169 11443872 (Pubitemid 32574062)
21. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Takada A, Kawaoka Y, Rev Med Virol 2003 13 387 398 10.1002/rmv.405 14625886 (Pubitemid 37413260)
22. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors. Ierino FL, Hulett MD, McKenzie IF, Hogarth PM, J Immunol 1993 150 1794 1803 7679695 (Pubitemid 23129655)
23. The role of influenza virus gene constellation and viral morphology on cytokine induction, pathogenesis, and viral virulence. Peiris JS, Poon LM, Nicholls JM, Guan Y, Hong Kong Med J 2009 15 21 23
24. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. Cheung CY, Poon LL, Ng IH, Luk W, Sia SF, Wu MH, Chan KH, Yuen KY, Gordon S, Guan Y, Peiris JS, J Virol 2005 79 7819 7826 10.1128/JVI.79.12.7819-7826.2005 15919935 (Pubitemid 40756816)
25. Neutralizing antibody response and SARS severity. Ho MS, Chen WJ, Chen HY, Lin SF, Wang MC, Di J, Lu YT, Liu CL, Chang SC, Chao CL, King CC, Chiou JM, Su IJ, Yang JY, Emerg Infect Dis 2005 11 1730 1737 10.3201/eid1111.040659 16318725 (Pubitemid 41628351)
26. Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome. Lee N, Chan PK, Ip M, Wong E, Ho J, Ho C, Cockram CS, Hui DS, J Clin Virol 2006 35 179 184 10.1016/j.jcv.2005.07.005 16112612 (Pubitemid 43053394)
27. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. Zhang L, Zhang F, Yu W, He T, Yu J, Yi CE, Ba L, Li W, Farzan M, Chen Z, Yuen KY, Ho D, J Med Virol 2006 78 1 8 10.1002/jmv.20499 16299724 (Pubitemid 41783837)
28. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM, Lancet Infect Dis 2010 10 712 722 10.1016/S1473-3099(10)70166-3 20883967
29. Fc receptor biology. Daeron M, Annu Rev Immunol 1997 15 203 234 10.1146/annurev.immunol.15.1.203 9143687 (Pubitemid 27169280)
30. Fcgamma receptors as regulators of immune responses. Nimmerjahn F, Ravetch JV, Nat Rev Immunol 2008 8 34 47 10.1038/nri2206 18064051
31. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, Daeron M, Blood 2009 113 3716 3725 10.1182/blood-2008-09-179754 19018092
32. Biology of immunoreceptor tyrosine-based inhibition motif-bearing molecules. Daeron M, Vivier E, Curr Top Microbiol Immunol 1999 244 1 12 10453645 (Pubitemid 29304666)
33. Differences in endocytosis mediated by FcgammaRIIA and FcgammaRIIB2. Zhang CY, Booth JW, Mol Immunol 2011 49 329 337 10.1016/j.molimm.2011.09.003 21945020
34. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). Rodrigo WW, Jin X, Blackley SD, Rose RC, Schlesinger JJ, J Virol 2006 80 10128 10138 10.1128/JVI.00792-06 17005690 (Pubitemid 44522606)
35. The spike protein of SARS-CoV-a target for vaccine and therapeutic development. Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S, Nat Rev Microbiol 2009 7 226 236 10.1038/nrmicro2090 19198616
36. Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease. Enjuanes L, Dediego ML, Alvarez E, Deming D, Sheahan T, Baric R, Virus Res 2008 133 45 62 10.1016/j.virusres.2007.01.021 17416434 (Pubitemid 351384650)
37. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B, Proc Natl Acad Sci U S A 2004 101 6641 6646 10.1073/pnas.0401939101 15096611 (Pubitemid 38586027)
38. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, Collins PL, Proc Natl Acad Sci U S A 2004 101 9804 9809 10.1073/pnas.0403492101 15210961 (Pubitemid 38869317)
39. Vaccine-induced enhancement of viral infections. Huisman W, Martina BE, Rimmelzwaan GF, Gruters RA, Osterhaus AD, Vaccine 2009 27 505 512 10.1016/j.vaccine.2008.10.087 19022319
40. Animal coronavirus vaccines: lessons for SARS. Saif LJ, Dev Biol (Basel) 2004 119 129 140 15742624
41. Immunogenicity of recombinant feline infectious peritonitis virus spike protein in mice and kittens. Vennema H, de Groot RJ, Harbour DA, Dalderup M, Gruffydd-Jones T, Horzinek MC, Spaan WJ, Adv Exp Med Biol 1990 276 217 222 10.1007/978-1-4684-5823-7-30 1966406
42. The middle East respiratory syndrome - how worried should we be? Perlman S, MBio 2013 4 00531 13 23963179
43. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS, Lancet 2002 360 1831 1837 10.1016/S0140-6736(02)11772-7 12480361 (Pubitemid 35449422)
44. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. Nicholls JM, Butany J, Poon LL, Chan KH, Beh SL, Poutanen S, Peiris JS, Wong M, PLoS Med 2006 3 27 10.1371/journal.pmed. 0030027 16379499 (Pubitemid 43362875)
45. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Holness CL, Simmons DL, Blood 1993 81 1607 1613 7680921 (Pubitemid 23083842)
46. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY, HKU/UCH SARS Study Group, Lancet 2003 361 1767 1772 10.1016/S0140-6736(03)13412-5 12781535 (Pubitemid 36638424)
47. Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR. Gillim-Ross L, Taylor J, Scholl DR, Ridenour J, Masters PS, Wentworth DE, J Clin Microbiol 2004 42 3196 3206 10.1128/JCM.42.7.3196-3206.2004 15243082 (Pubitemid 38938080)
48. Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Poon LL, Chan KH, Wong OK, Cheung TK, Ng I, Zheng B, Seto WH, Yuen KY, Guan Y, Peiris JS, Clin Chem 2004 50 67 72 10.1373/clinchem.2003.023663 14709637 (Pubitemid 38125700)